Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Left ventricular hypertrophy as a risk factor.

E D Frohlich

    Cardiology Clinics
    |February 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Left ventricular hypertrophy (LVH) is the heart adapting to high blood pressure, but it increases risks for heart problems and sudden death. Research is exploring how LVH can be reversed with medication.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Preventive cardiology: more than just lipid lowering.

    Preventive cardiology·2002
    Same author

    Profiles in cardiology. Harriet P. Dustan.

    Clinical cardiology·2002
    Same author

    Sixtieth anniversary of Angiotensin.

    Hypertension (Dallas, Tex. : 1979)·2001
    Same author

    Apoptosis and glomerular injury after prolonged nitric oxide synthase inhibition in spontaneously hypertensive rats.

    Hypertension (Dallas, Tex. : 1979)·2001
    Same author

    Local hemodynamic changes in hypertension: insights for therapeutic preservation of target organs.

    Hypertension (Dallas, Tex. : 1979)·2001
    Same author

    Isolated systolic hypertension in elderly WKY is reversed with L-arginine and ACE inhibition.

    Hypertension (Dallas, Tex. : 1979)·2001
    Same journal

    At the Edge of the Possible: A New Standard for Cardiovascular Critical Care.

    Cardiology clinics·2026
    Same journal

    End-of-Life Care in the Cardiovascular Intensive Care Unit.

    Cardiology clinics·2026
    Same journal

    Strategies to Reduce Failure to Rescue after Cardiac Surgery.

    Cardiology clinics·2026
    Same journal

    Embracing Enhanced Recovery After Cardiac Surgery Program.

    Cardiology clinics·2026
    Same journal

    Post-Heart Transplantation Intensive Care Unit Recovery: A Phase-Based Approach.

    Cardiology clinics·2026
    Same journal

    A Practical Guide to Intensive Care Unit Management after Left Ventricular Assist Device Implantation.

    Cardiology clinics·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Pathophysiology
    • Molecular Biology

    Context:

    • Left ventricular hypertrophy (LVH) is a common cardiac adaptation to pressure overload, particularly in hypertensive diseases.
    • While initially adaptive, LVH can progress to heart failure.
    • Epidemiological studies link LVH to increased cardiovascular morbidity and mortality.

    Purpose:

    • To summarize the adaptive and maladaptive aspects of left ventricular hypertrophy.
    • To highlight the associated cardiovascular risks and mortality.
    • To introduce emerging research on the regression of LVH with pharmacologic interventions.

    Summary:

    • Left ventricular hypertrophy (LVH) is the heart's structural response to increased afterload, maintaining function until decompensation occurs.

    Related Experiment Videos

  • LVH is associated with significant risks, including cardiovascular events, ischemic disease, arrhythmias, and sudden death.
  • Mechanisms underlying LVH and its potential regression via specific pharmacologic therapies are areas of active investigation.

    • Impact:

    • Understanding LVH mechanisms can lead to targeted therapies for hypertensive heart disease.
    • Identifying patients at high risk for LVH complications is crucial for preventative cardiology.
    • Research into LVH regression may offer novel treatment strategies to improve cardiac outcomes and reduce mortality.